Meñoza, Bb Boy 1 .

HRN: 21-99-09  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/03/2023
CEFTRIAXONE 1G (VIAL)
05/03/2023
05/10/2023
IV
280mg
OD
Sepsis
Waiting Final Action 
05/03/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/03/2023
05/10/2023
IV
60mg
OD
Sepsis
Waiting Final Action 
05/03/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/03/2023
05/10/2023
IV
40mg
Q8
Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: